RevMAb Biosciences histone family protein monoclonal antibodies
02 May, 2024RevMAb Biosciences offers a wide range of recombinant monoclonal antibodies against histone family proteins including antibodies against histone modifications such as acetylation, phosphorylation and methylation of different histones.
Biosensis MAP2 antibodies
05 April, 2024Biosensis's validated MAP2 antibodies are designed to help users identify MAP2, whether they are detecting MAP2a, MAP2b or the distinctive MAP2c variant.
Bio-Rad Laboratories Celselect Slides validated antibodies for rare cell and CTC enumeration
02 April, 2024The antibodies are specific to CTC surface markers to enable the sensitive and specific identification of target cell populations, enhancing the study of tumour heterogeneity and disease progression at various stages.
ProSci Incorporated ferroptosis antibodies
20 March, 2024ProSci Incorporated's range of ferroptosis antibodies includes AIFM2, NCOA4, PEX3, PEX10, FLT3, LPCAT3, GPX4, SLC7A11 and ferritin.
GeneTex HistoMAX IHC-validated Antibodies
11 March, 2024GeneTex has introduced its HistoMAX product line that consists of antibodies specifically vetted for IHC.
Beckman Coulter Life Sciences anti-TRBC2 conjugated antibody for flow cytometry
12 January, 2024The anti-TRBC2 conjugated antibody provides greater clarity to clinical researchers in the identification of T-cell neoplasms in areas including cancer research.
Biosensis alpha-synuclein antibodies
09 January, 2024Biosensis offers alpha-synuclein antibodies to support advancement in neuroscience and neurodegenerative disease research.
Abnova Camelid Single Domain Antibody Service
12 December, 2023A camelid single-domain antibody (sdAb), also known as a VHH or nanobody, is the recombinant variable domain derived from a camelid heavy-chain-only antibody.
Aves Lab anti-mCherry antibody
06 November, 2023Aves Labs' anti-mCherry chicken primary antibody is a sensitive reagent for detection of mCherry by western blot, immunocytochemistry and immunohistochemistry.
Bio-Rad Laboratories anti-idiotypic antibodies
12 October, 2023Bio-Rad Laboratories has extended its range of recombinant monoclonal anti-idiotypic antibodies with the introduction of six antibodies specific to dupilumab (Dupixent) and the addition of new evolocumab (Repatha), ipilimumab (Yervoy), and secukinumab (Cosentyx) antibodies.
Biosensis CNPase antibodies
11 October, 2023Biosensis' CNPase antibodies enable effective labelling, visualisation and quantification within tissues or cultures.
ChromoTek Ubiquitin-Trap
01 September, 2023The ChromoTek Ubiquitin-Trap consists of an anti-ubiquitin nanobody/VHH, coupled to either standard agarose beads or magnetic agarose beads.
Bio-Rad Laboratories StarBright Red 670 and expanded antibody marker range
31 August, 2023Bio-Rad Laboratories has announced its 29th StarBright Dye, StarBright Red 670, and the addition of 29 highly validated antibodies conjugated to the StarBright Blue 700 and StarBright Violet 610 Dyes.
Potent antibodies neutralise COVID-19, other coronaviruses
04 August, 2023Researchers have discovered exceptionally potent antibodies that can neutralise virtually all known variants of the COVID-19 virus, as well as other animal coronaviruses.
Proteintech CoraLite Plus conjugated antibodies
01 June, 2023Proteintech's CoraLite Plus Conjugated Antibodies aim to provide faster and brighter immunofluorescence experiments.
